Curis
CRIS
#10972
Rank
NZ$1.18 M
Marketcap
NZ$0.61
Share price
-17.89%
Change (1 day)
-78.87%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.43. In 2024 the company made an earnings per share (EPS) of NZ-$12.32 an increase over its 2023 EPS that were of NZ-$15.83.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-48.2%
2024NZ-$12.32-22.15%
2023NZ-$15.83-26.17%
2022NZ-$21.4422.3%
2021NZ-$17.53-25.37%
2020NZ-$23.49-30.93%
2019NZ-$34.00-2.02%
2018NZ-$34.71
2016NZ-$78.88-10%
2015NZ-$87.64138.1%
2014NZ-$36.8140%
2013NZ-$26.29-25%
2012NZ-$35.0666.67%
2011NZ-$21.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.30-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.24-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.63-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.49-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.82 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.70 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.47-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA